The occurrence of a novel coronavirus known as severe acute respiratory syndrome-
coronavirus-2 (SARS-CoV-2), created a serious challenge worldwide. SARS-CoV-2 has …

Abstract On March 11, 2020, the World Health Organization declared Coronavirus Disease
2019 (COVID-19) a pandemic. Till now, it affected 452.4 million (Spain, 11.18 million) …

Recently, scientists developed a powerful strategy called “one drug-multiple targets” to
discover vital and unique therapies to fight the most challenging diseases. Novel derivatives …

Considering the imminence of new SARS-CoV-2 variants and COVID-19 vaccine
availability, it is essential to understand the impact of the disease on the most vulnerable …

COPD is predicted to become the third leading cause of morbidity and mortality worldwide
by 2030. Cigarette smoking (active or passive) is one of its chief causes, with about 20% of …

Since the emergence of COVID 19, the authentic SARS-CoV-2 has evolved into a range of
novel variants that are of more global concern. In late November 2021, the Omicron (lineage …

Cardiovascular diseases (CVDs) are the main contributors to global morbidity and mortality.
Major pathogenic phenotypes of CVDs include the development of endothelial dysfunction …

Therapeutic approaches with immune‐modulatory effects such as probiotics and prebiotics
adjuvant therapy may be essential to combat against COVID‐19 pandemic. The present trial …

SARS-CoV-2 continues to pose a major challenge to scientists and clinicians. We examined
the significance of the serum concentrations of vitamin D, albumin, and D-dimer for the …

Omicron (B. 1.1. 529) was first detected in a sample collected in Botswana on November 11,
2021, and has rapidly replaced Delta as the dominant global variant given the robust …